Drugs Made In America Acquisition (DMIIR) Free Cash Flow (2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Free Cash Flow came in at -$314864.0 in Q4 2025.

Drugs Made In America Acquisition (DMIIR) Free Cash Flow (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 1 years of Free Cash Flow data on file, last reported at -$314864.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - -121,028.00
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - 1.32 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - -119,667.00
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - 10,832.00
5 Centurion Acquisition 311.65 Mn 311.65 Mn - -72,157.00
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - -147,921.00
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - -207,911.00
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - -133,997.00
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - -171,240.00
10 Drugs Made In America Acquisition - - - -314,864.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -314,864.00
Dec 31, 2025 -314,864.00